PharmaJet Archives - BioTuesdays

Developments

Vaccine publishes study demonstrating benefits of PharmaJet’s Tropis needle-free system

Closely held PharmaJet announced the publication of a study in the top-tier journal Vaccine, which demonstrates the benefits of the company’s Tropis needle-free system compared to needle and syringe (N/S) for...

May 1, 2025

Developments

PharmaJet to present insights from DNA cancer vaccine partner trials at WVC 2025

Closely held PharmaJet announced it will present insights from several DNA cancer vaccine partner trials using PharmaJet’s Precision Delivery Systems at the World Vaccine Congress (WVC) on April 23, 2025 at 12:25 pm ET...

April 17, 2025

Developments

PharmaJet spotlights Nature publication on Stratis IM System benefits

Closely held PharmaJet has announced that the peer-reviewed journal Nature has published findings from a U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) Phase 1 trial, demonstrating that the...

December 10, 2024

Developments

PharmaJet’s innovative needle-free system chosen for WHO polio immunization campaign in Somalia

Closely-held PharmaJet announced that its Tropis Intradermal (ID) Needle-free System was selected by WHO for use in a house-to-house immunization campaign targeting more than 170,000 children, age four to 59 months, in...

June 27, 2024

Developments

PharmaJet launches Phase 1 trial of Precision Delivery Systems-delivered VEE vaccine

PharmaJet launched a Phase 1 clinical study evaluating a Venezuelan Equine Encephalitis (VEE) DNA vaccine delivered via the company’s needle-free Precision Delivery Systems. The Phase 1 trial, sponsored by PharmaJet and...

November 17, 2023

Developments

PharmaJet launches Nigerian study of Tropis-administered poliovirus vaccine

PharmaJet launched a study in Nigeria to evaluate the intradermal administration of a fractional inactivated poliovirus vaccine (fIPV) using the company’s Tropis ID Needle-free Injection System. Children at 22 urban and...

October 25, 2023

Developments

PharmaJet partner, Scancell, posts positive data from Phase 2 advanced melanoma trial

PharmaJet partner, Scancell, reported positive data from the first phase of a Phase 2 clinical trial evaluating PharmaJet’s needle-free vaccine delivery system for treatment of advanced melanoma. The Phase 2 study’s...

September 28, 2023

Executive Moves

Former Pfizer vaccine president Nanette Cocero joins PharmaJet board

PharmaJet appointed Nanette Cocero, Ph.D., a recognized leader in the global pharmaceutical industry with broad commercial and business experience coupled with an extensive clinical and scientific background, to the...

July 12, 2023

Developments

PharmaJet Tropis system authorized for 2 nucleic acid vaccines

PharmaJet’s Tropis system is now the exclusive intradermal delivery system for two authorized novel COVID-19 vaccines. They include: The world’s first plasmid DNA COVID-19 vaccine for administration in humans from Zydus...

June 28, 2023

Executive Moves

Marie Mazur appointed chair of PharmaJet board

PharmaJet named Marie Mazur, PharmD, chairwoman of the board, replacing Ron Lowy, who had chaired the board since 2011. “Marie’s experience and leadership will be of great benefit for our company as we are accelerating...

June 6, 2023

Tag - PharmaJet

Vaccine publishes study demonstrating benefits of PharmaJet’s Tropis needle-free system

PharmaJet to present insights from DNA cancer vaccine partner trials at WVC 2025

PharmaJet spotlights Nature publication on Stratis IM System benefits

PharmaJet’s innovative needle-free system chosen for WHO polio immunization campaign in Somalia

PharmaJet launches Phase 1 trial of Precision Delivery Systems-delivered VEE vaccine

PharmaJet launches Nigerian study of Tropis-administered poliovirus vaccine

PharmaJet partner, Scancell, posts positive data from Phase 2 advanced melanoma trial

Former Pfizer vaccine president Nanette Cocero joins PharmaJet board

PharmaJet Tropis system authorized for 2 nucleic acid vaccines

Marie Mazur appointed chair of PharmaJet board

Subscribe